Novel use of contrast-enhanced susceptibility imaging (CE-SWI) in assessing treatment response in extremity soft-tissue undifferentiated pleomorphic sarcoma (UPS)

Congress:

ECR 2024

Poster Number:

C-11059

Type:

Scientific Exhibit

Keywords:

Musculoskeletal soft tissue, MR, MR-Functional imaging, Computer Applications-Detection, diagnosis, Cancer

Authors:

R. F. Valenzuela, E. Duran-Sierra, M. Canjirathinkal, C. Costelloe, J. Madewell, W. Murphy, B. Amini

DOI:

10.26044/ecr2024/C-11059

DOI-Link:

https://dx.doi.org/10.26044/ecr2024/C-11059

Personal information and conflict of interest

R. F. Valenzuela: Nothing to disclose

E. Duran-Sierra: Nothing to disclose

M. Canjirathinkal: Nothing to disclose

C. M. Costelloe: Nothing to disclose

J. E. Madewell: Nothing to disclose

W. Murphy: Nothing to disclose

B. Amini: Nothing to disclose

Fig 1: SWI image processing workflow developed in this study.

Fig 2: CE-SWI morphological patterns across treatment.

Fig 3: Representative CE-SWI post-radiation morphology patterns.

Fig 4: Morphological patterns of CE-SWI at post-radiation by response.

Fig 5: Complete hemosiderin ring as a UPS CE-SWI pattern of response.

Fig 6: Radiomics of CE-SWI ring morphology.

Fig 7: UPS CE-SWI radiomics at post-chemotherapy (PC).

Fig 8: UPS CE-SWI radiomics at post-radiation (PRT).